Detection And Clinical Significance Of Glomerular M-Type Phospholipase A(2) Receptor In Patients With Idiopathic Membranous Nephropathy

H Liu,W Luo,S Gong,X Ding

DOI: https://doi.org/10.1111/imj.13233

2016-01-01

Internal Medicine Journal

Abstract:BackgroundGlomerular M-type phospholipase A(2) receptor (PLA(2)R) is important for diagnosing idiopathic membranous nephropathy (IMN). The relation between glomerular PLA(2)R expression and response to treatment remains to be explored.AimsWe conducted the study to explore the positive rate and clinical significance of glomerular M-type PLA(2)R in IMN patients.MethodsA total of 122 IMN patients receiving neither glucocorticoid nor immunosuppressant therapy prior to renal biopsies was included and followed for more than 1year. The control group comprised 30 patients with secondary membranous nephropathy and 100 patients with non-membranous forms of nephropathy. PLA(2)R level and IgG subclasses in glomeruli were detected. The primary end-point was the reduction of proteinuria to less than 50% of baseline value.ResultsA total of 82.0% of patients with IMN had positive glomerular PLA(2)R deposits, compared with 16.7% in the secondary membranous nephropathy group (P<0.001). Additionally, PLA(2)R-positive expression combined with IgG42+ was found in 94.3% IMN patients, compared with 40.0% in secondary membranous nephropathy patients (P<0.01). Among IMN patients, the remission rate of proteinuria after either glucocorticoid or glucocorticoid combined immunosuppressant therapy for at least 6months was 83.9% in the PLA(2)R-positive group compared with 54.5% in the negative group (P<0.05).ConclusionThe positive rate of glomerular PLA(2)R was more prevalent in IMN patients. Both PLA(2)R and IgG4 glomerular deposits may help in discriminating between idiopathic and secondary membranous nephropathy. IMN patients with positive PLA(2)R expression probably have a more beneficial response to glucocorticoid and/or immunosuppressant therapy.